Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Immunology  |  Musculoskeletal  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Lupus Clinical Trials

A listing of Lupus medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (4) clinical trials

Efficacy of 595 nm Pulsed-dye Laser in Treatment of Discoid Lupus Erythematosus

forty DLE lesions from patients will be recruited in the study. The lesions on one side of the body were block-randomized into the treatment group and the other side served as a control. The patients can continue their systemic treatments and the PDL is designed to be used as an ...

Phase

Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis

Sarcoidosis is a multisystem disorder of unknown etiology characterized by granulomatous inflammation involving various body organs. The diagnosis is made on the basis of compatible clinicoradiological feature, histopathologic evidence of non-caseating granuloma, and exclusion of other known causes for granulomatous inflammation. As the lung and mediastinal lymph nodes are the ...

Phase

Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension

Primary Endpoint: Change in 6 minute walk distance. Secondary Endpoints: - Safety - Oxygen saturation at rest and with exercise - Hospitalization - Mortality - WHO functional class - Quality of life as measured by - Short-form 36 - Sarcoidosis Health Questionnaire - Dyspnea as measured by - Borg Dyspnea ...

Phase

An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

Background: Statins are lipid-lower agents with pleiotropic effects. Beyond the traditional effect as inhibitors of 3-hydroxy-3methylglytaryl coenzyme A (HMG-CoA) reductase, it has anti-inflammatory and immunomodulatory properties. The administration of atorvastatin to lupus-prone model NZB/W F1 mice results in a significant reduction in serum IgG anti-dsDNA Abs and decreased proteinuria. In ...

Phase